Molecular Characteristics of Isolated From Chinese Children With Different Diseases.

Dingle Yu, Yunmei Liang, Qinghua Lu, Qing Meng, Wenjian Wang, Lu Huang, Yanmin Bao, Ruizhen Zhao, Yunsheng Chen, Yuejie Zheng, Yonghong Yang
Author Information
  1. Dingle Yu: Microbiology Laboratory, National Center for Children's Health, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Beijing, China.
  2. Yunmei Liang: Beijing Chaoyang Hospital Affiliated to the Capital Medical University, Beijing, China.
  3. Qinghua Lu: Microbiology Laboratory, National Center for Children's Health, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Beijing, China.
  4. Qing Meng: Shenzhen Children's Hospital, Shenzhen, China.
  5. Wenjian Wang: Shenzhen Children's Hospital, Shenzhen, China.
  6. Lu Huang: Shenzhen Children's Hospital, Shenzhen, China.
  7. Yanmin Bao: Shenzhen Children's Hospital, Shenzhen, China.
  8. Ruizhen Zhao: Shenzhen Children's Hospital, Shenzhen, China.
  9. Yunsheng Chen: Shenzhen Children's Hospital, Shenzhen, China.
  10. Yuejie Zheng: Shenzhen Children's Hospital, Shenzhen, China.
  11. Yonghong Yang: Microbiology Laboratory, National Center for Children's Health, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Beijing, China.

Abstract

is a bacterial pathogen that causes a wide spectrum of clinical diseases exclusively in humans. The distribution of type, antibiotic resistance and virulence gene expression for varies temporally and geographically, resulting in distinct disease spectra. In this study, we analyzed antibiotic resistance and resistance gene expression patterns among isolates from pediatric patients in China and investigated the relationship between virulence gene expression, type, and disease categories. Forty-two representative 1.0 and 12.0 strains ( = 20 and = 22, respectively) isolated from patients with scarlet fever or obstructive sleep apnea-hypopnea syndrome were subjected to whole-genome sequencing and phylogenetic analysis. These strains were further analyzed for susceptibility to vancomycin. We found a high rate and degree of resistance to macrolides and tetracycline in these strains, which mainly expressed and . The disease category correlated with type but not superantigens. The distribution of and virulence genes were associated with type. Previously reported important prophages, such as φHKU16.vir, φHKU488.vir, Φ5005.1, Φ5005.2, and Φ5005.3 encoding streptococcal toxin, and integrative conjugative elements (ICEs) such as ICE-emm12 and ICE-HKU397 encoding macrolide and tetracycline resistance were found present amongst 1 or 12 clones from Shenzhen, China.

Keywords

References

  1. Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2361-2371 [PMID: 32676802]
  2. Nucleic Acids Res. 2020 Jan 8;48(D1):D517-D525 [PMID: 31665441]
  3. PLoS Pathog. 2012;8(6):e1002736 [PMID: 22719247]
  4. Eur J Clin Microbiol Infect Dis. 2015 Sep;34(9):1797-802 [PMID: 26024763]
  5. Nucleic Acids Res. 2009 Jan;37(Database issue):D443-7 [PMID: 18832362]
  6. Emerg Infect Dis. 1999 Mar-Apr;5(2):247-53 [PMID: 10221877]
  7. Indian J Med Res. 2018 Jan;147(1):81-87 [PMID: 29749365]
  8. Nucleic Acids Res. 2007;35(9):3100-8 [PMID: 17452365]
  9. Bioinformatics. 2012 Dec 1;28(23):3150-2 [PMID: 23060610]
  10. Lancet Infect Dis. 2020 Jan;20(1):24-25 [PMID: 31876494]
  11. J Invest Dermatol. 2019 Jun;139(6):1284-1293 [PMID: 30543898]
  12. Microb Drug Resist. 2014 Oct;20(5):431-5 [PMID: 24571416]
  13. Infect Immun. 1999 Sep;67(9):4307-11 [PMID: 10456867]
  14. Front Public Health. 2018 Mar 09;6:59 [PMID: 29662874]
  15. Nat Genet. 2015 Jan;47(1):84-7 [PMID: 25401300]
  16. Bioinformatics. 2007 Mar 15;23(6):673-9 [PMID: 17237039]
  17. J Clin Microbiol. 2020 Mar 25;58(4): [PMID: 31996443]
  18. Lancet Infect Dis. 2020 Jul;20(7):780 [PMID: 32592668]
  19. J Med Microbiol. 2012 Jul;61(Pt 7):975-983 [PMID: 22442290]
  20. Infect Genet Evol. 2020 Dec;86:104609 [PMID: 33147506]
  21. Epidemiol Infect. 2002 Jun;128(3):397-404 [PMID: 12113483]
  22. J Clin Microbiol. 2010 Mar;48(3):842-51 [PMID: 20042624]
  23. Antimicrob Agents Chemother. 2007 Apr;51(4):1228-33 [PMID: 17242142]
  24. Mikrobiyol Bul. 2018 Jul;52(3):233-246 [PMID: 30156510]
  25. J Pediatr Adolesc Gynecol. 2021 Dec;34(6):799-804 [PMID: 34166822]
  26. J Med Microbiol. 2006 Aug;55(Pt 8):1115-1123 [PMID: 16849733]
  27. Front Microbiol. 2018 Mar 23;9:542 [PMID: 29628918]
  28. Infect Immun. 2002 Dec;70(12):7095-104 [PMID: 12438391]
  29. Microbiol Spectr. 2019 Jan;7(1): [PMID: 30737912]
  30. Nat Commun. 2020 Oct 6;11(1):5018 [PMID: 33024089]
  31. J Clin Med. 2021 May 10;10(9): [PMID: 34068785]
  32. EBioMedicine. 2018 Feb;28:128-135 [PMID: 29342444]
  33. Int J Med Microbiol. 2007 Oct;297(6):471-8 [PMID: 17481952]
  34. Lancet Infect Dis. 2009 Oct;9(10):611-6 [PMID: 19778763]
  35. Clin Microbiol Rev. 2014 Apr;27(2):264-301 [PMID: 24696436]
  36. Expert Rev Anti Infect Ther. 2015 May;13(5):615-28 [PMID: 25746210]
  37. FEMS Microbiol Lett. 2003 Dec 12;229(2):259-64 [PMID: 14680708]
  38. Gigascience. 2018 Jan 1;7(1):1-6 [PMID: 29220494]
  39. Eur J Clin Microbiol Infect Dis. 2016 May;35(5):747-54 [PMID: 26873375]
  40. An Pediatr (Engl Ed). 2020 Jun;92(6):351-358 [PMID: 31879253]
  41. Eur J Clin Microbiol Infect Dis. 2017 Sep;36(9):1643-1649 [PMID: 28401320]
  42. mSphere. 2020 Apr 29;5(2): [PMID: 32350098]
  43. Diagn Microbiol Infect Dis. 2010 Aug;67(4):369-75 [PMID: 20638606]
  44. Eur J Clin Microbiol Infect Dis. 2012 May;31(5):859-65 [PMID: 21877175]
  45. J Microbiol Immunol Infect. 2021 Dec;54(6):1086-1093 [PMID: 32994137]
  46. Clin Infect Dis. 2020 Jun 24;71(1):201-204 [PMID: 31630171]
  47. Infect Dis (Lond). 2019 Sep;51(9):668-675 [PMID: 31282243]
  48. J Biol Chem. 2014 Dec 19;289(51):35225-36 [PMID: 25378402]
  49. Front Microbiol. 2017 Jun 08;8:1052 [PMID: 28642756]
  50. Infect Immun. 2000 Jun;68(6):3523-34 [PMID: 10816507]
  51. Nucleic Acids Res. 2019 Jan 8;47(D1):D687-D692 [PMID: 30395255]
  52. PLoS One. 2017 Jul 18;12(7):e0180757 [PMID: 28719668]
  53. Lancet Infect Dis. 2005 Nov;5(11):685-94 [PMID: 16253886]
  54. Epidemiol Infect. 2009 Oct;137(10):1414-9 [PMID: 19243651]

Word Cloud

Created with Highcharts 10.0.0resistancetypediseaseantibioticvirulencegeneexpressionChina1strainsΦ5005distributionanalyzedpatients012=foundtetracyclinevirencodingbacterialpathogencauseswidespectrumclinicaldiseasesexclusivelyhumansvariestemporallygeographicallyresultingdistinctspectrastudypatternsamongisolatespediatricinvestigatedrelationshipcategoriesForty-tworepresentative2022respectivelyisolatedscarletfeverobstructivesleepapnea-hypopneasyndromesubjectedwhole-genomesequencingphylogeneticanalysissusceptibilityvancomycinhighratedegreemacrolidesmainlyexpressedcategorycorrelatedsuperantigensgenesassociatedPreviouslyreportedimportantprophagesφHKU16φHKU48823streptococcaltoxinintegrativeconjugativeelementsICEsICE-emm12ICE-HKU397macrolidepresentamongstclonesShenzhenMolecularCharacteristicsIsolatedChineseChildrenDifferentDiseasesStreptococcuspyogeneschildemmsuperantigen

Similar Articles

Cited By